Explore UAB

Please note: 
The UAB MGL will be lifting the moratorium for the RNA-based biopsy testing of CAL spots on January 3, 2023 (test code: NF14C). To request the required culture media, please complete a kit request here. Instructions for collection and shipment of these specimens can be found here.

The moratorium for the RNA-based biopsy testing of neurofibromas will remain in place until further notice (test code: NF14N*).

*Neurofibromas can still be tested using next generation sequencing but cannot be tested via RNA

Given the rapidly changing situation and the complexities of these testing approaches, please contact the MGL if you are considering this test or would like to discuss a specific case.

For more information regarding the Medical Genomics Laboratory holiday closures and sample receival availability, please see Holiday Closures


The Medical Genomics Laboratory (MGL) is a CAP-certified nonprofit clinical laboratory at the University of Alabama at Birmingham, offering comprehensive testing for common and rare genetic disorders.  The MGL specializes in testing for all forms of the neurofibromatoses including NF1, Legius syndrome (SPRED1 disorder), segmental NF, NF-Noonan, spinal NF, Watson syndrome, NF2, and schwannomatosis as well as the RASopathies, and tuberous sclerosis complex. 


UAB Medical Genomics Laboratory
720 20th St. S., Suite 330
Birmingham, AL 35294
Phone: 205.934.5562
Fax: 205.996.2929
E-mail: medgenomics@uabmc.edu 

Tell us how we are doing! Please complete our customer satisfaction survey and share your feedback! Please click here for survey